David Melin

Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium.

Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.

Cybernetics, Inc. specializes in the design and manufacture of high performance data solutions. Its solutions include virtualization, storage area network, unified storage, data backup, disaster recovery. The company was founded in 1978 and is headquartered in Yorktown, VA.

Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany.

Swedish Trade Council provides business development services and is ultimately controlled by the Government of Sweden. The company is based in Stockholm, Sweden.

Navamedic AB purchases and in-licenses pharmaceuticals and other healthcare products. Its commodities include drugs for: mouth and throat problems, dermatologic, urologic, gynecologic, cardiologic, and other disorders. The company was founded in 1999 and is headquartered in Molndal, Sweden.

Globen Ögonklinik AB operates a chain of laser eye surgery clinics. It runs laser eye surgery clinics in Sweden and Norway. The company was founded in 1995 and is headquartered in Johanneshov, Sweden

Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada

Part of Abbott Laboratories, NeoPharma AB is a Swedish pharmaceutical preparation company. The company is based in Vastra Gotaland, Sweden. The company was founded by Sten-Magnus Aquilonius, Lars Christer Nyström.

Fresenius Kabi AB specializes in clinical nutrition, infusion therapy, and medical technology. It offers products for the collection and treatment of blood components and for the treatment of patient blood through therapeutic apheresis. The firm also develops products with a focus on oncology and autoimmune diseases. The company is headquartered in Uppsala, Sweden.

Alkalon A/S engages in the development of pharmaceutical industry. It focuses on developing and commercializing medicated chewing gum formulations. The firm also owns portfolio of nicotine gums approved for smoking cessation and smoking reduction. The company was founded by Bo Tandrup in 2007 and is headquartered in Copenhagen, Denmark.

Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.

Abilia Sverige Holding AB develops, manufactures, and trades assistive technology for persons with disabilities. The company is headquartered in Solna, Sweden.

Observe Medical ApS develops medical devices for digital monitoring of a patients’ urine output. Its brands include sippsense, sippcoat, sippbag, and sipplink. The company was founded on June 26, 2010 and is headquartered in Kongens Lyngby, Denmark.

ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium.

LobSor Holding AB owns and manages shares and participations. The company is headquartered in Uppsala, Sweden.

Tridentify AB provides monitoring and quality assurance of blood bags. It products include the Tracer, the Access Point, the Check-in Node, the Web Portal and the Reader. The company was founded in 2009 by Petra Lindberg and Magnus Gramming and is headquartered in Gothenburg, Sweden.

Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland.

Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany.

Acarix A/S engages in development, production and advertisement of a new cardiovascular diagnostic methods and equipment. It develops engages in the non-invasive and non-radiation acoustic detection of coronary artery disease. The firm designs CADScor, a sensor that records, processes, and displays heart signal. The company was founded in 2009 and is headquartered in Kongens Lyngby, Denmark.

Ponscasa Holding AB is a Swedish company that manages real estate property and provides business consulting services. The private company is based in Uppsala, Sweden. The CEO of the company is Ulf Rosén.

Biotech Invest I Albano AB manages and sells fixed and movable property. The private company is based in Stockholm, Sweden.

InTrance Holding AB is an investment holding Swedish company. The company is based in Uppsala, Sweden. The company was founded in 2018 by Ulf Rosén.

Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea.